View Older Stories View More Recent Stories

Feb 5, 2018 08:15AM Cancer Genetics (CGIX) Announces CEO Panna Sharma to Step Down; Appoints John Roberts Interim
Feb 5, 2018 08:12AM Cancer Genetics, Inc. Chief Executive Officer Steps Down
Jan 17, 2018 07:30AM Cancer Genetics Expands Its Industry-Leading Immuno-Oncology Panel, Complete::IO™, to be the Most Comprehensive for Immune Profiling & Monitoring
Dec 28, 2017 07:09AM Cancer Genetics (CGIX) Secures Non-Dilutive Funding $1.1M from New Jersey Technology Business Tax Certificate Transfer Program
Dec 28, 2017 07:00AM Cancer Genetics Receives Non-Dilutive Funding of $1.1 Million through New Jersey Technology Business Tax Certificate Transfer (NOL) Program
Dec 19, 2017 07:39AM Cancer Genetics (CGIX) Announces New York State Approval for FDA-Approved Oncomine Dx Target Test by Thermo Fisher Scientific (TMO)
Dec 19, 2017 07:30AM Cancer Genetics Receives New York State Approval for FDA-Approved Oncomine Dx Target Test by Thermo Fisher Scientific
Dec 11, 2017 07:30AM Cancer Genetics advances understanding of immune response and measurement in lymphomas by combining PD-L1 expression analysis with RNA analysis
Dec 8, 2017 08:59AM Cancer Genetics (CGIX) Prices $7M Registered Direct Offering of 3.5M Units
Dec 8, 2017 08:58AM Cancer Genetics Prices $7 Million Registered Direct Offering
Nov 30, 2017 08:00AM Cancer Genetics to Participate in Upcoming Investor Conferences
Nov 29, 2017 08:02AM Cancer Genetics Initiates Partnership to Reduce Alarmingly Increasing Cancer Mortality Rates in India
Nov 27, 2017 08:02AM Cancer Genetics (CGIX) Appoints Thomas Widmann to its Board of Directors
Nov 27, 2017 08:00AM Cancer Genetics Appoints Renowned Biotech Entrepreneur Dr. Thomas F. Widmann to its Board of Directors
Nov 9, 2017 07:22AM Cancer Genetics Reports Record Third Quarter 2017 Revenue and 134% Increase in Contracted Bookings from Major Biotech and Pharmaceutical Companies
Nov 8, 2017 07:30AM Cancer Genetics to Present Insights to Advance Precision Medicine in Non-Small Cell Lung Cancer (NSCLC) at AMP Annual Meeting 2017
Oct 31, 2017 07:45AM Cancer Genetics Named One of the Top 10 Drug Discovery & Development Solution Providers by Panel of Industry Experts at Pharma Tech Outlook 
Oct 12, 2017 07:30AM Cancer Genetics, Inc. to Host Panel Discussion on “The Convergence of Artificial Intelligence and Healthcare - New Developments in Precision Medicine” During the 3rd Annual Dawson James Small Cap
Sep 22, 2017 08:00AM Cancer Genetics, Inc. to Present at the 2017 Disruptive Growth Company Showcase NYC on September 27th
Sep 20, 2017 09:22AM Cancer Genetics, Inc. Announces 25th Contract Win to Provide Testing & Diagnostic Services for Combination Immuno-Oncology Clinical Trial
Aug 16, 2017 07:00AM Cancer Genetics, Inc. to Host Conference Call to Discuss Strategic and Business Rationale of vivoPharm Acquisition
Aug 14, 2017 05:02PM Cancer Genetics (CGIX) Announces Acquisition of vivoPharm for $12M
Aug 14, 2017 05:01PM Cancer Genetics Announces Transformative and Accretive Acquisition of vivoPharm, a Global Oncology & Immuno-Oncology Discovery Services Company
Aug 14, 2017 04:56PM Cancer Genetics, Inc. Announces Second Quarter 2017 Financial Results, Accretive Acquisition and Capital Raise
Aug 7, 2017 04:30PM Cancer Genetics to Hold Second Quarter 2017 Earnings Call on Monday, August 14th
Aug 3, 2017 07:30AM DIA Elects Cancer Genetics, Inc.’s John A. (Jay) Roberts as Chairman of DIA Board of Directors
Jul 27, 2017 07:00AM Cancer Genetics, Inc. Acclaimed by Frost & Sullivan For North American Technology Innovation in Precision Oncology
Jun 27, 2017 07:36AM Cancer Genetics (CGIX) Launches Companion Diagnostic for Lung Cancer Leveraging Thermo Fisher's Oncomine Dx Target Test
Jun 27, 2017 07:35AM Cancer Genetics, Inc. Launches FDA-Approved Universal Companion Diagnostic for Lung Cancer Leveraging Thermo Fisher's Next Generation Sequencing Panel Oncomine Dx Target Test
Jun 2, 2017 07:59AM Cancer Genetics, Inc. to Present at the 7th Annual LD Micro Invitational
May 15, 2017 07:08AM Cancer Genetics (CGIX) Partners with Roche's Ventana Medical Systems
May 15, 2017 07:00AM Cancer Genetics, Inc. Partners with Ventana Medical Systems, Inc., a member of the Roche Group, to Ensure Market Access to Predictive Biomarker Test for New Immuno-Oncology (IO) Therapy for Advanced B
May 11, 2017 06:23PM Cancer Genetics, Inc. Announces 15% Revenue Increase in First Quarter of 2017 over 2016 on Strong Organic Growth While Continuing on Path to Profitability
May 8, 2017 07:48AM Cancer Genetics (CGIX) Launches Multi-Gene Liquid Biopsy Test For Lung Cancer Patients
May 8, 2017 07:33AM Cancer Genetics, Inc. Changes The Paradigm For Lung Cancer Monitoring – Launches Clinically Actionable, Multi-Gene, Liquid Biopsy Test For Lung Cancer Patients, Liquid::Lung-cfDNA™
May 5, 2017 08:48AM Cancer Genetics to Hold First Quarter 2017 Earnings Call on Friday, May 12th
Apr 25, 2017 07:00AM Cancer Genetics, Inc. to Present at The Pioneers 2017 Conference Presented by Joseph Gunnar & Co., LLC
Apr 24, 2017 07:20AM Cancer Genetics, Inc. Launches a Unique, Industry-Leading Panel That Provides Comprehensive & Precise Information for Immuno-Oncology Therapy Assessment & Patient Monitoring
Apr 10, 2017 07:00AM Cancer Genetics, Inc. is Selected by eFFECTOR Therapeutics to Provide Biomarker Discovery and Development Services for Novel Oncology Drugs
Apr 3, 2017 07:07AM Cancer Genetics (CGIX) Confirms Partnership with Mendel Health Enabling Artificial Intelligence in Precision Medicine for Cancer Care
Apr 3, 2017 07:00AM Cancer Genetics, Inc. and Mendel.ai Announce Strategic Partnership Enabling Artificial Intelligence in Precision Medicine to Drive Personalized Treatment and Accelerate Clinical Trial Matching for Can
Mar 28, 2017 04:10PM Cancer Genetics, Inc. to Present at The MicroCap Conference on April 4th at 08:00 AM in New York City
Mar 23, 2017 07:30AM Cancer Genetics, Inc. Announces Record Revenue for Fourth Quarter and Full-Year 2016 and Provides 2017 Business Update
Mar 10, 2017 11:41AM Cancer Genetics to Report Fourth Quarter & Year End 2016 Earnings and Business Update on March 23
Feb 23, 2017 02:34PM Cancer Genetics India Partners with CSIR-Centre for Cellular and Molecular Biology to Organize the 2nd Annual Next Generation Sequencing Conference in India
Feb 22, 2017 08:12AM Cancer Genetics, Inc. to Receive $1.0 Million in Non-Dilutive Funding Through New Jersey Technology Business Tax Certificate Transfer Program
Feb 16, 2017 08:15AM Cancer Genetics, Inc. Hereditary Breast & Ovarian Cancer Panel Selected by Global Biopharma to Power 1,000+ Patient Clinical Study
Feb 13, 2017 07:30AM Cancer Genetics, Inc. to Present at the 2nd Annual Disruptive Growth & Healthcare Conference
Jan 25, 2017 12:49PM Cancer Genetics, Inc. Launches Entry into Comprehensive Hereditary Cancer Testing for Breast & Ovarian Cancers, Addressing a $2.5 Billion Market
Jan 17, 2017 09:33AM Cancer Genetics (CGIX), Lantern Pharma Announce Strategic Collaboration
View More Recent Stories View Older Stories